Results 21 to 30 of about 135,691 (213)

Case Report: A New Entity: Multiple Differentiated Variant of Papillary Thyroid Carcinoma With Advanced Clinical Behavior

open access: yesFrontiers in Endocrinology, 2021
There are many histological morphological types of papillary thyroid carcinoma (PTC), but the most frequently seen types are conventional. A single PTC commonly has a conventional and/or a variant morphological pattern.
Jing Yang   +6 more
doaj   +1 more source

The landscape of TIGIT target and clinical application in diseases

open access: yesMedComm – Oncology, 2022
Immune checkpoint blockade has dramatically altered the concept of cancer therapeutics over the past few years. Beyond the existing classical pathways, novel immune checkpoints, such as T‐cell immunoglobulin and immunoreceptor tyrosine‐based inhibitory ...
Shu Rui   +10 more
doaj   +1 more source

Complement C4-A and Plasminogen as Potential Biomarkers for Prediction of Papillary Thyroid Carcinoma

open access: yesFrontiers in Endocrinology, 2021
BackgroundEarly diagnosis and therapy of papillary thyroid carcinoma (PTC) is essential for reducing recurrence and improving the long-term survival. In this study, we aimed to investigate the proteome profile of plasma and screen unique proteins which ...
Yichao Wang   +12 more
doaj   +1 more source

The Frequency of Synchronous Parathyroid Adenomas and Papillary Thyroid Carcinomas: Clinicopathological Evaluation

open access: yes, 2022
Objective: We aimed to evaluate the frequency and clinicopathological features of papillary thyroid carcinomas synchronized with parathyroid adenoma and to compare the “parathyroid adenoma with papillary thyroid carcinoma” and “parathyroid adenoma ...
ÖZTÜRK, TÜLİN   +9 more
core   +1 more source

Primary hyperparathyroidism in young patients is associated with metabolic disorders: a prospective comparative study

open access: yesBMC Endocrine Disorders, 2023
Background Components of metabolic syndrome can be observed in patients with primary hyperparathyroidism (PHPT). The link between these disorders remains unclear due to the lack of relevant experimental models and the heterogeneity of examined groups ...
Ekaterina E. Bibik   +10 more
doaj   +1 more source

Non-Linear Correlation Between Tumor Size and Survival Outcomes for Parathyroid Carcinoma: A SEER Population-Based Cohort Study

open access: yesFrontiers in Endocrinology, 2022
BackgroundParathyroid carcinoma (PC) is a rare malignancy without a commonly acknowledged prognostic assessment and treatment system. This study captures how independent prognostic factors and tumor size correlate with outcomes in patients with PC ...
Kun Zhang   +11 more
doaj   +1 more source

Parathyroid Carcinoma: Update on Pathogenesis and Therapy

open access: yes, 2023
Parathyroid carcinoma (PC) is a very rare endocrine cancer with aggressive behavior, a high metastatic potential, and a poor prognosis. Surgical resection of affected gland(s) and other involved structures is the elective therapy. Pre-operative and intra-
Cinzia Aurilia   +5 more
core   +1 more source

Lymph node metastasis between the sternocleidomastoid and sternohyoid muscle in papillary thyroid carcinoma patients: A prospective study at multiple centers

open access: yesAsian Journal of Surgery, 2021
Background: The lymph nodes between the sternocleidomastoid and sternohyoid muscle (LNSS) are not explicitly mentioned in the 2015 American Thyroid Association and 2008 American Head and Neck Society (AHNS) guidelines, but they are easily overlooked in ...
Linlin Song   +9 more
doaj   +1 more source

Prognostic Nomogram and Competing Risk Analysis of Death for Primary Thyroid Lymphoma

open access: yesAnnals of Surgery Open, 2022
Background:. Primary thyroid lymphoma (PTL) is such a rare malignancy that there are no large-scale prognostic proofs to create a consensus on optimal management.
Kun Zhang, MD, PhD   +5 more
doaj   +1 more source

Updates of Genomics and Proteomics of Parathyroid Carcinoma

open access: yes, 2022
Parathyroid carcinoma is a rare disease that needs an additional diagnostic tool and wide therapeutic options. The genomics and proteomics approach may help to find the tools to improve the prognosis of the disease by early detection and metastatic ...
Sung Hye Kong
core   +1 more source

Home - About - Disclaimer - Privacy